Poor provider adherence to the centers for disease control and prevention treatment guidelines in US emergency department visits with a diagnosis of pelvic inflammatory disease

Sexually Transmitted Diseases

Volumn 38, Issue 4, 2011, Pages 299-305

  Shih, Ting Yu ^a   Gaydos, Charlotte A ^a   Rothman, Richard E ^a   Hsieh, Yu Hsiang ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; DOXYCYCLINE; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PROBENECID;

ADULT; ARTICLE; EMERGENCY WARD; FEMALE; HUMAN; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; SINGLE DRUG DOSE; UNITED STATES;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS-SECTIONAL STUDIES; DEMOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; ODDS RATIO; PATIENT DISCHARGE; PELVIC INFLAMMATORY DISEASE; UNITED STATES; YOUNG ADULT;

EID: 79953224750     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31820b8bb4     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Pelvic Inflammatory Disease (PID). Available at: http://www2a.cdc.gov/stdtraining/ready-to-use/Manuals/PID/ pid-slides-2009.pdf. Accessed August 15, 2010.
2. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-6):1-78.
3. Pelvic inflammatory disease: Guidelines for prevention and management. MMWR Recomm Rep 1991; 40(RR-5):1-25.
4. 1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Recomm Rep 1993; 42(RR-14):1-102.
5. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47(RR-1):1-111.
6. Sexually transmitted diseases treatment guidelines 2006. Centers for Disease Control and Prevention. MMWR Recomm Rep 2006; 55(RR-11):1-94.
7. Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis 1996; 23:157-163. (Pubitemid 26109060)
8. Hillis SD, Joesoef R, Marchbanks PA, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168:1503-1509. (Pubitemid 23153297)
9. Marchbanks PA, Annegers JF, Coulam CB, et al. Risk factors for ectopic pregnancy. A population-based study. JAMA 1988; 259: 1823-1827. (Pubitemid 18080862)
10. U.S. Department of Health and Human Services. Healthy people 2000: National health promotion and disease prevention objectives. Full report with commentary. Department of Health and Human Services publication PHS 91-60212. Washington, DC: U.S. Department of Health and Human Services, 1991.
11. Healthy People 2010, 2nd ed. Available at: http://www.healthy people.gov/Document/tableofcontents.htm. Accessed January 11, 2010.
12. Curtis KM, Hilliss SD, Kieke BA, et al. Visits to emergency departments for gynecologic disorders in the United States, 1992-1994. Obstet Gynecol 1998; 91:1007-1012. (Pubitemid 28246941)
13. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 2008; 8:1-29.
14. Kane BG, Degutis LC, Sayward HK, et al. Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases. Acad Emerg Med 2004; 11:371-377. (Pubitemid 38437012)
15. Beckmann KR, Melzer-Lange MD, Gorelick MH. Emergency department management of sexually transmitted infections in US adolescents: Results from the National Hospital Ambulatory Medical Care Survey. Ann Emerg Med 2004; 43:333-338. (Pubitemid 38282643)
16. National Center for Health Statistics, Centers for Disease Control and Prevention. Ambulatory Health Care Data: National Hospital Ambulatory Medical Care Survey. Available at: http://www. cdc.gov/nchs/ahcd/about-ahcd.htm. Accessed August 5, 2009.
17. Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data 2007; 386:1-32.
18. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32:778-784. (Pubitemid 41752566)
19. U.S. Census Census Bureau, Population Division. Population Estimates Vintage 2006 Archive. Available at: http://www. census.gov/popest/archives/ 2000s/vintage-2006/. Accessed August 28, 2010.
20. Hsieh YH, Chen KF, Gaydos CA, et al. Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season. PLoS One 2010; 5:e8945.
21. Asaro PV, Sheldahl AL, Char DM. Embedded guideline information without patient specificity in a commercial emergency department computerized order-entry system. Acad Emerg Med 2006; 13:452-458.
22. Ozdas A, Speroff T, Waitman LR, et al. Integrating "best of care" protocols into clinicians' workflow via care provider order entry: Impact on quality-of-care indicators for acute myocardial infarction. J Am Med Inform Assoc 2006; 13:188-196. (Pubitemid 43332910)
23. Grol R. Improving the quality of medical care: Building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001; 286:2578-2585. (Pubitemid 33096809)
24. Lagoe R, Aspling DL, Westert GP. Current and future developments in managed care in the United States and implications for Europe. Health Res Policy Syst 2005; 3:4.
25. Curry SJ. Organizational interventions to encourage guideline implementation. Chest 2000; 118(suppl 2):40S-46S. (Pubitemid 30637777)
26. Haggerty CL, Ness RB. Diagnosis and treatment of pelvic in-flammatory disease. Womens Health (Lond Engl) 2008; 4:383-397.
27. Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res 2003; 31: 45-54. (Pubitemid 36335875)
28. Savaris RF, Teixeira LM, Torres TG, et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: A randomized controlled trial. Obstet Gynecol 2007; 110:53-60. (Pubitemid 47015700)
29. Haggerty CL, Ness RB. Newest approaches to treatment of pelvic inflammatory disease: A review of recent randomized clinical trials. Clin Infect Dis 2007; 44:953-960. (Pubitemid 46452060)
30. Walling AD. Tips from other journals: Azithromycin vs. doxycycline for the treatment of PID. Am Fam Physician 2008; 77:834-837.
31. Walker CK, Workowski KA, Washington AE, et al. Anaerobes in pelvic inflammatory disease: Implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999; 28(suppl 1):S29-S36. (Pubitemid 29249959)